Zoledronate, fractures, and mortality after hip fracture [4]
Publication
, Journal Article
Colon-Emeric, CS; Lyles, KW; Mesenbrink, P
Published in: New England Journal of Medicine
February 28, 2008
Duke Scholars
Published In
New England Journal of Medicine
EISSN
1533-4406
ISSN
0028-4793
Publication Date
February 28, 2008
Volume
358
Issue
9
Start / End Page
968 / 969
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Colon-Emeric, C. S., Lyles, K. W., & Mesenbrink, P. (2008). Zoledronate, fractures, and mortality after hip fracture [4]. New England Journal of Medicine, 358(9), 968–969.
Colon-Emeric, C. S., K. W. Lyles, and P. Mesenbrink. “Zoledronate, fractures, and mortality after hip fracture [4].” New England Journal of Medicine 358, no. 9 (February 28, 2008): 968–69.
Colon-Emeric CS, Lyles KW, Mesenbrink P. Zoledronate, fractures, and mortality after hip fracture [4]. New England Journal of Medicine. 2008 Feb 28;358(9):968–9.
Colon-Emeric, C. S., et al. “Zoledronate, fractures, and mortality after hip fracture [4].” New England Journal of Medicine, vol. 358, no. 9, Feb. 2008, pp. 968–69.
Colon-Emeric CS, Lyles KW, Mesenbrink P. Zoledronate, fractures, and mortality after hip fracture [4]. New England Journal of Medicine. 2008 Feb 28;358(9):968–969.
Published In
New England Journal of Medicine
EISSN
1533-4406
ISSN
0028-4793
Publication Date
February 28, 2008
Volume
358
Issue
9
Start / End Page
968 / 969
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences